Standard Operating Procedure for Control of Specifications Methods and Validation Documents
| Department | Regulatory Affairs |
| SOP No. | RA/2026/707 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 13/04/2026 |
| Effective Date | 13/04/2026 |
| Review Date | 13/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a consistent and controlled approach for the management, maintenance, and review of specifications, methods, and validation documents used across regulated activities. It ensures integrity, accuracy, timely updates, and compliance with applicable regulatory requirements and internal quality standards, thereby supporting product quality assurance and regulatory readiness.
Scope
This SOP applies to all activities related to the creation, revision, approval, distribution, storage, archiving, and disposal of specifications, analytical/testing methods, and validation-related documents within Regulatory Affairs and cross-functional departments such as Quality Control, Quality Assurance, Manufacturing, and Validation. It encompasses documents associated with any dosage forms, equipment, processes, or functional areas. This SOP excludes non-regulated documents and those controlled under other specific procedural manuals.
Responsibilities
The following roles are involved in the execution of this SOP:
- Document Owner: Responsible for drafting, revising, and ensuring accuracy of the documents.
- Quality Assurance: Reviews and approves documents for compliance and suitability.
- Regulatory Affairs: Maintains regulatory compliance and document control systems.
- Validation/Analytical Team: Contributes technical data and method validation details.
- Records Management: Controls distribution, storage, and archiving of documents.
- Supervisors/Managers: Ensure personnel adhere to the SOP and facilitate training.
Accountability
The Head of Regulatory Affairs is accountable for the implementation, ongoing compliance, periodic review, escalation of issues, and verification of the effectiveness of this SOP. This includes ensuring adequate resources, training, and updates to align with changing regulatory or organizational requirements.
Procedure
1. Preparation and Prerequisites: The Document Owner identifies the need for new or revised specifications, methods, or validation documents based on regulatory requirements, process changes, deviations, or continuous improvement initiatives.
2. Document Drafting: Using approved templates, the Document Owner drafts or revises the document ensuring clarity, completeness, and compliance with applicable guidelines and standards.
3. Internal Review and Verification: The draft document undergoes technical and quality review by relevant stakeholders, including validation or analytical representatives, to verify data and method robustness.
4. Approval and Authorization: After satisfactory review, Quality Assurance and Regulatory Affairs review the final document for conformance. Formal approval signatures or electronic validation are obtained before release.
5. Control and Distribution: The approved document is assigned a unique controlled number/version and recorded in the document control system. Distribution is limited to authorized personnel only, with obsolete versions withdrawn promptly.
6. Training: Personnel affected by document updates receive appropriate training or communication to ensure awareness and compliance.
7. Implementation and Use: The document is utilized in respective operations such as testing, validation activities, submissions, or compliance checks following GMP guidelines.
8. Monitoring and Deviations: Any non-compliance, deviations, or changes affecting controlled documents must be documented and investigated, with corrective actions implemented as necessary.
9. Periodic Review: Documents are reviewed at predefined intervals or as triggered by regulatory changes or organizational needs. Reviews verify continued adequacy, accuracy, and relevance.
10. Archiving and Retention: All superseded or obsolete documents are archived securely for the retention period defined by regulatory and company policies to ensure traceability and audit readiness.
11. Closure: Upon completion or discontinuation of any related project or activity, final documentation and records are secured and made available for inspection.
This procedure applies flexibly across specifications, testing and validation methodologies, and any relevant documentations ensuring system integrity, compliance, and traceability in a regulated pharmaceutical environment.
Abbreviations
GMP – Good Manufacturing Practice
SOP – Standard Operating Procedure
QA – Quality Assurance
QC – Quality Control
RA – Regulatory Affairs
UUID – Unique Universal Identifier (for document reference)
CSV – Computer System Validation
Documents
The following documents are required for proper execution and control of specifications, methods, and validation documents:
- Document Control Form for Specifications and Methods (Annexure-1)
- Validation Protocol and Report Template (Annexure-2)
- Document Revision and Training Log (Annexure-3)
References
1. ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
2. FDA 21 CFR Part 11: Electronic Records; Electronic Signatures
3. EMA GMP Guidelines
4. ISO 9001:2015 Quality Management Systems Requirements
5. Company Quality Manual and Document Control Policy
6. Pharmacopoeial Standards (USP, Ph.Eur., JP as applicable)
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Document Control Form for Specifications and Methods
Purpose: To record detailed information and control actions related to the issuance, revision, and distribution of specification and method documents.
| Document Title | Assay Method for Active Pharmaceutical Ingredient |
|---|---|
| Document Number | SOP-RD-001 |
| Version | 1.0 |
| Date of Issue | 13/04/2026 |
| Prepared By | |
| Checked By | |
| Approved By | |
| Distribution List | QA, QC, Manufacturing, Regulatory Affairs |
| Remarks | Initial issue |
Annexure-2: Validation Protocol and Report Template
Purpose: To standardize validation execution and reporting for analytical methods or process validation supporting regulatory documentation.
| Validation Title | HPLC Method Validation for API Assay |
|---|---|
| Protocol Number | VAL-HPLC-2026-01 |
| Version | 1.0 |
| Start Date | 15/04/2026 |
| Completion Date | 30/04/2026 |
| Responsible Analyst | |
| Reviewer | |
| Approver | |
| Summary of Results | Method passed all acceptance criteria including accuracy, precision, linearity, and robustness. |
| Deviation(s) Noted | None |
Annexure-3: Document Revision and Training Log
Purpose: To track revisions of controlled documents and confirm training of affected personnel on the updated content.
| Document Title | Assay Method for Active Pharmaceutical Ingredient |
|---|---|
| Document Number | SOP-RD-001 |
| Revision Number | 1.0 |
| Date of Revision | 13/04/2026 |
| Summary of Changes | Initial issue of the document |
| Personnel Trained | QC Analysts, Validation Team, Regulatory Affairs Staff |
| Training Date | 14/04/2026 |
| Trainer Name | [Trainer] |
| Training Acknowledgement | Completed and documented |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 13/04/2026 | 1.0 | Initial issue | New SOP creation |